Related Experiment Video

Updated: Aug 31, 2025

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.4K

CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non-Small Cell

Xuehan Chen1, Yanzhuo Liu1, Yang Wang1

  • 1Department of Pharmacology and Hubei Province Key Laboratory of Allergy and Immune-related Diseases, School of Basic Medical Sciences, Wuhan University, Wuhan, China.

Cancer Research
|August 25, 2022
PubMed
Abstract

Insights

Researchers found that CYP4F2 metabolism helps non-small cell lung cancer evade immune attack. Inhibiting CYP4F2 may boost immunotherapy effectiveness for lung cancer patients.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Non-small cell lung cancer (NSCLC) exhibits immune evasion mechanisms.
  • The role of specific metabolic pathways in NSCLC immune evasion is not fully understood.

Purpose of the Study:

  • To investigate the role of CYP4F2-dependent metabolism in NSCLC immune evasion.
  • To explore CYP4F2 inhibition as a therapeutic strategy to enhance immunotherapy efficacy.

Main Methods:

  • Utilized molecular and cellular assays to study CYP4F2 function in NSCLC.
  • Assessed the impact of CYP4F2 inhibition on immune cell infiltration and anti-tumor immune responses.
  • Evaluated the combination of CYP4F2 inhibitors with immunotherapy agents in preclinical models.

Main Results:

  • CYP4F2-dependent metabolism was identified as a key driver of immune evasion in NSCLC.
  • Inhibition of CYP4F2 restored anti-tumor immune responses and sensitized tumors to immunotherapy.
  • Targeting CYP4F2 holds potential for overcoming resistance to current immunotherapies.

Conclusions:

  • CYP4F2 plays a critical role in facilitating immune evasion in non-small cell lung cancer.
  • Inhibiting CYP4F2 represents a promising strategy to enhance the effectiveness of cancer immunotherapy.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.3K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

533

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
428
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K